<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>A novel approach to profile global circulation pathway of SARS-CoV-2 variants by site-based mutation dynamics - Health AI Hub</title>
    <meta name="description" content="This paper introduces the Site-based mutation dynamics - Equal Power Sampling (S-EPS) framework, a novel phylogenetic-free and bias-correcting method for profil">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>A novel approach to profile global circulation pathway of SARS-CoV-2 variants by site-based mutation dynamics</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.22841v1" target="_blank">2511.22841v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-28
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Hong Zheng, Shimin Su, Caiqi Liu, Jingzhi Lou, Lirong Cao, Yexian Zhang, Zhihui Zhang, Marc Ka Chun Chong, Benny Chung-Ying Zee, Peter Pak-Hang Cheung, Haogao Gu, Juan Pu, Leo Lit Man Poon, Hui-Ling Yen, Maggie Haitian Wang
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.PE, q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.22841v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.22841v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces the Site-based mutation dynamics - Equal Power Sampling (S-EPS) framework, a novel phylogenetic-free and bias-correcting method for profiling global SARS-CoV-2 variant source-sink dynamics. Applying S-EPS to 6.6 million genomes, the study identified Africa and the Indian subcontinent as predominant sources of key mutations, established a predictive model for global spread from these sources, and highlighted the framework's utility for enhanced genetic surveillance of emerging viral threats.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Understanding the global dispersal patterns of SARS-CoV-2 variants, including their origins and spread dynamics, is critical for effective public health surveillance, early identification of new threats, and informing timely interventions such as vaccine updates or targeted travel advisories. This framework provides a predictive tool to anticipate the spread of clinically significant mutations.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The S-EPS framework is a novel, phylogenetic-free, bias-correcting computational framework designed to profile viral source-sink dynamics and predict the global spread of key mutations. While not explicitly labeled as 'AI,' it functions as an advanced predictive analytics tool, processing large-scale genomic data to provide critical foresight for public health decision-making and early warning systems for emerging viral threats. This aligns with AI/computational applications in bioinformatics, epidemiology, and health surveillance.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>**Development of S-EPS Framework:** A novel, phylogenetic-free, and bias-correcting framework designed to profile viral source-sink dynamics, specifically applied to SARS-CoV-2.</li>
                    
                    <li>**Extensive Data Application:** The framework was applied to a large dataset of 6.6 million SARS-CoV-2 genomes collected from March 2020 to June 2024 across 13 global regions.</li>
                    
                    <li>**Identification of Global Source Regions:** Africa and the Indian subcontinent were identified as primary sources for key SARS-CoV-2 mutations.</li>
                    
                    <li>**Characterization of Transmission Roles:** Southeast Asia was found to act as an early transmission hub, while Russia and South America primarily functioned as viral sinks.</li>
                    
                    <li>**Mutation Establishment Dynamics:** Key mutations took longer to establish fitness and prevalence within their source regions compared to external regions.</li>
                    
                    <li>**Predictive Model for Global Spread:** An amino acid substitution on the receptor-binding domain (RBD) reaching 1% prevalence in major source regions has an 80% probability of spreading globally, with a median lead time of 2 months (IQR: 1-4 months).</li>
                    
                    <li>**Enhanced Surveillance Capability:** The S-EPS framework offers an improved capability for genetic surveillance and the proactive monitoring of emerging viral threats.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study developed the Site-based mutation dynamics - Equal Power Sampling (S-EPS) framework. This novel methodology is described as a phylogenetic-free and bias-correcting approach specifically designed to profile viral source-sink dynamics. It was applied to an extensive dataset comprising 6.6 million SARS-CoV-2 genomes collected globally from 13 distinct regions over a period spanning from March 2020 to June 2024, to analyze mutation dynamics and identify regional roles in viral circulation.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Africa and the Indian subcontinent were identified as the predominant global sources for key SARS-CoV-2 mutations. Southeast Asia served as an early transmission hub, while Russia and South America typically acted as viral sinks. The study revealed that key mutations required a longer time to establish fitness within their source regions compared to external environments. Critically, it established a predictive metric: an amino acid substitution on the receptor-binding domain (RBD) reaching 1% prevalence in major source regions indicates an 80% probability of spreading elsewhere globally, with a median lead time of 2 months (interquartile range: 1-4 months).</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The S-EPS framework provides a powerful, predictive tool for public health authorities to enhance genetic surveillance and early warning systems for emerging SARS-CoV-2 variants. By identifying potential source regions and predicting the global spread of key mutations with a significant lead time, it can enable proactive implementation of mitigation strategies, inform vaccine development and updates, guide diagnostic test improvements, and facilitate targeted public health interventions ahead of widespread outbreaks, ultimately improving epidemic preparedness and response.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the S-EPS framework or the study findings. However, implicit limitations could include potential biases in global genomic sequencing efforts (even with a 'bias-correcting' framework), the generalizability of findings to other pathogens, or the specific definition and impact of 'key mutations' which might require further biological validation.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The paper implies future directions through its conclusion, emphasizing the S-EPS framework's utility for enhanced monitoring of emerging viral threats. This suggests ongoing application of S-EPS for continuous global genetic surveillance of SARS-CoV-2, potential adaptation and validation for other rapidly evolving pathogens, and further refinement of the predictive model for mutation spread and lead times.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Infectious Disease Epidemiology</span>
                    
                    <span class="tag">Public Health</span>
                    
                    <span class="tag">Virology</span>
                    
                    <span class="tag">Genomic Surveillance</span>
                    
                    <span class="tag">Computational Biology</span>
                    
                    <span class="tag">Evolutionary Biology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">SARS-CoV-2</span>
                    
                    <span class="tag tag-keyword">viral variants</span>
                    
                    <span class="tag tag-keyword">genetic surveillance</span>
                    
                    <span class="tag tag-keyword">source-sink dynamics</span>
                    
                    <span class="tag tag-keyword">mutation dynamics</span>
                    
                    <span class="tag tag-keyword">receptor-binding domain</span>
                    
                    <span class="tag tag-keyword">phylogenetic-free</span>
                    
                    <span class="tag tag-keyword">epidemic waves</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The genetic evolution of SARS-CoV-2 has caused recurring epidemic waves, understanding its global dispersal patterns is critical for effective surveillance. We developed the Site-based mutation dynamics - Equal Power Sampling (S-EPS) framework, a phylogenetic-free, bias-correcting framework for profiling viral source-sink dynamics. Applying S-EPS to 6.6 million SARS-CoV-2 genomes (March 2020 - June 2024) from 13 regions worldwide, we identified Africa and the Indian subcontinent as the predominant sources of key mutations. Southeast Asia serves as an early transmission hub, while Russia and South America mainly acted as sinks. Key mutations took longer to establish fitness in source regions than externally. Once an amino acid substitution on the receptor-binding domain reached 1% prevalence in major sources, there is an 80% probability it would spread elsewhere, with a 2-month median lead time (IQR: 1-4). Our findings underscore the importance of genetic surveillance, with S-EPS offering enhanced capability for monitoring emerging viral threats.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>